Search
for
Sort by
Research 61–90 of 1000+
- Aldesleukin
- Docetaxel.
- Bioactive inorganic particles‐based biomaterials for skin tissue engineering
- The pharmacology of methotrexate
- Methotrexate in dermatology
- Recent advances in the treatment of psoriasis
- EFFECT OF "AMINOPTERIN" ON EPITHELIAL TISSUES
- INTERFERONS IN DERMATOLOGY
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Adverse effects of voriconazole: Over a decade of use
- Ocular involvement caused by the accumulation of porphyrins in a patient with congenital erythropoietic porphyria
- “PRIDE” Complex
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Polymeric Nanohydrogel in Topical Drug Delivery System
- TOC
- Topical absorption and systemic toxicity
- Effect of adenosine triphosphate on ribociclib-induced skin toxicity in rats
- Effects of adenosine triphosphate on vandetanib induced skin damage in rats
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- 1312 Nrf2 activation enhances the healing of cutaneous wounds through the activation of hair follicle stem cells
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Enhanced cutaneous wound healing by functional injectable thermo-sensitive chitosan-based hydrogel encapsulated human umbilical cord-mesenchymal stem cells
- Basic concepts, current evidence, and future potential for gene therapy in managing cutaneous wounds
- Cutaneous Markers of Disorders Affecting Adult Horses
- 17th national conference of association of cutaneous surgeons (I) (ACSICON 2019)––conference report
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Cutaneous drug reactions
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team